KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Non Operating Income (2016 - 2026)

Chemed filings provide 18 years of Non Operating Income readings, the most recent being -$1000.0 for Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income fell 100.08% year-over-year to -$1000.0, compared with a TTM value of $5.3 million through Mar 2026, down 89.68%, and an annual FY2025 reading of $19.3 million, down 44.52% over the prior year.
  • Non Operating Income hit -$1000.0 in Q1 2026 for Chemed, down from $5.3 million in the prior quarter.
  • The five-year high for Non Operating Income was $34.7 million in Q4 2024, with the low at -$4.9 million in Q2 2022.
  • Median Non Operating Income over the past 5 years was $1.2 million (2025), compared with a mean of $5.2 million.
  • The largest YoY upside for Non Operating Income was 686000.0% in 2023 against a maximum downside of 10200.0% in 2023.
  • Year by year, Non Operating Income stood at $12.3 million in 2022, then plummeted by 63.05% to $4.5 million in 2023, then surged by 665.23% to $34.7 million in 2024, then crashed by 84.71% to $5.3 million in 2025, then tumbled by 100.02% to -$1000.0 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$1000.0, $5.3 million, and -$7000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.